Trials / Terminated
TerminatedNCT05999292
Phase 1 Study of 68Ga-R8760
Phase 1 Safety and Dosimetry Study of 68Ga-R8760 in Patients With Adrenocortical Carcinoma and Healthy Volunteers
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Radionetics Oncology · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A Phase 1 Safety and Dosimetry Study of 68Ga-R8760 in Patients with Adrenocortical Carcinoma and Healthy Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 68Ga-R8760 injection at pre-defined dose levels | PET/CT imaging at predefined timepoints |
| DRUG | 68Ga-R8760 injection | PET/CT imaging at a single timepoint |
Timeline
- Start date
- 2023-09-11
- Primary completion
- 2024-05-23
- Completion
- 2024-05-23
- First posted
- 2023-08-21
- Last updated
- 2024-12-09
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05999292. Inclusion in this directory is not an endorsement.